Reverse osmosis membrane and method of producing the same
US-2024307831-A1 · Sep 19, 2024 · US
US11279731B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-11279731-B2 |
| Application number | US-201816174373-A |
| Country | US |
| Kind code | B2 |
| Filing date | Oct 30, 2018 |
| Priority date | Mar 28, 2011 |
| Publication date | Mar 22, 2022 |
| Grant date | Mar 22, 2022 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
A substrate comprising a crosslinked polymer primer layer, and grafted thereto a ligand-functionalized polymer is provided. The grafted polymer has the requisite affinity for binding neutral or negatively charged biomaterials, such as cells, cell debris, bacteria, spores, viruses, nucleic acids, and proteins, at pH's near or below the pI's of the biomaterials.
Opening claim text (preview).
The invention claimed is: 1. A ligand functional substrate comprising: a) a substrate, and b) a crosslinked ligand-functional alkenyl (co)polymer layer coated on the surface of the substrate, wherein the ligand-functional alkenyl (co)polymer comprises polymerized monomer units of the formula: wherein R 1 is H or C 1 -C 4 alkyl; R 2 is a divalent alkylene having 1 to 20 carbon atoms; each R 3 is independently H or C 1 -C 4 alkyl; R 4 is H, C 1 -C 4 alkyl or —N(R 3 ) 2 ; R 5 is H or C 1 -C 4 alkyl or aryl; X 1 is —O— or —NR 3 —, o is 0 or 1, and n is 1 or 2. 2. The ligand-functional substrate of claim 1 , wherein the ligand-functional alkenyl (co)polymer further comprises polymerized hydrophilic monomer units. 3. The ligand-functional substrate of claim 2 , wherein the ligand-functional alkenyl (co)polymer comprises 1% to about 70% by weight polymerized hydrophilic monomer units, relative to the total monomer weight. 4. The ligand-functional substrate of claim 2 , wherein the ligand-functional alkenyl (co)polymer comprises 5% to about 50% by weight polymerized hydrophilic monomer units, relative to the total monomer weight. 5. The ligand-functional substrate of claim 2 , wherein the hydrophilic monomer units are poly(oxyalkylene) (meth)acrylate monomer units. 6. The ligand-functional substrate of claim 5 , wherein the poly(oxyalkylene) (meth)acrylate monomer units are of the formula: CH 2 ═CR 1 —C(O)—X 1 —(CH(R 1 )—CH 2 —O) n —R 1 , wherein each R 1 is independently H or C 1 -C 4 alkyl, X 1 is—O— or —NR 3 —, where R 3 is H or C 1 -C 4 alkyl and n is 2 to 100. 7. The ligand-functional substrate of claim 1 , wherein the ligand-functional alkenyl (co)polymer further comprises polymerized cationic or anionic monomer units. 8. The ligand-functional substrate of claim 7 , wherein the anionic monomer units are selected from (meth)acryloylsulfonic acids, vinylsulfonic acid, 4-styrenesulfonic acid; (meth)acrylamidophosphonic acids; (meth)acrylic acid and carboxyalkyl(meth)acrylates. 9. The ligand-functional substrate of claim 7 , wherein the cationic monomer units are selected from amino (meth)acrylates, amino (meth)acrylamides, dialkylaminoalkylamine adducts of alkenylazlactones, and quaternary ammonium salts thereof. 10. The ligand-functional substrate of claim 1 , wherein the crosslinking agent of said crosslinked ligand-functional alkenyl (co)polymer layer is a multifunctional (meth)acryloyl monomer. 11. The ligand-functional substrate of claim 10 , wherein the multifunctional (meth)acryloyl monomer is selected from di(meth)acrylates, tri(meth)acrylates, and tetra(meth)acrylates. 12. The ligand-functional substrate of claim 10 , wherein the multifunctional (meth)acryloyl monomer is selected from ethyleneglycol di(meth)acrylate, 1,6-hexanediol di(meth)acrylate, poly(ethylene glycol) di(meth)acrylates, polybutadiene di(meth)acrylate, polyurethane di(meth)acrylates, propoxylated glycerin tri(meth)acrylate, methylenebisacrylamide, ethylenebisacrylamide, hexamethylenebisacrylamide, and diacryloylpiperazine. 13. The ligand-functional substrate of claim 10 , wherein the multifunctional (meth)acryloyl monomer is used in amounts of 0.25% to about 5% by weight, relative to the total monomer weight. 14. The ligand-functional substrate of claim 1 , wherein the crosslinked ligand- functional alkenyl (co)polymer layer is of the formula: -(M Lig ) y -(M Hydrophil ) x (M crosslink ) z -, where (M Hydrophil) x are hydrophilic monomer units having “x” polymerized monomer units, (M Lig ) y are ligand functional monomer units having “y” polymerized monomer units, (M crosslink ) are multifunctional (meth)acryloyl monomer units having “y” polymerized monomer units, y is 10 to less than 100 wt.% of the monomer units; x is 0 to 90 wt.% of the monomer units; z is greater than 0 to 5% wt.% of the monomer units, based on 100 wt.% total monomers. 15. The ligand-functional substrate of claim 1 wherein said ligand-functional alkenyl (co)polymer comprises 5 to 30 wt.% of the ligand functional substrate. 16. The ligand-functional substrate of claim 1 wherein the substrate is a porous substrate selected from porous particles, porous membranes, porous nonwoven webs, and porous fibers. 17. A method of preparing a ligand functional substrate of claim 1 comprising the steps of: a) providing a substrate, b) free-radically reacting the substrate with a ligand-functional (meth)acryloyl monomer of the formula: wherein R 1 is H or C 1 -C 4 alkyl; R 2 is a divalent alkylene having 1 to 20 carbon atoms; each R 3 is independently H or C 1 -C 4 alkyl; R 4 is H, C 1 -C 4 alkyl or —N(R 3 ) 2 ; R 5 is H or C 1 -C 4 alkyl or aryl; X 1 is —O— or —NR 3 —, o is 0 or 1, and n is 1 or 2, in a mixture with a multifunctional (meth)acryloyl monomer. 18. The method of claim 17 further comprising free-radically reacting with a hydrophilic monomer.
by introduction of specific groups after membrane formation, e.g. by grafting · CPC title
Polyamides, e.g. polyester-amides · CPC title
with an insoluble carrier for immobilising immunochemicals · CPC title
Affinity chromatography or related techniques based upon selective absorption processes · CPC title
involving radiation · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.